We are currently conducting a research study for children with Epilepsy. The medication being tested is approved in the United States for the treatment of Epilepsy. This study is looking at an extended release form of this medication. Children between ages 6 to 12 years Have a diagnosed history of epilepsy but are otherwise healthy Are on a current dose if carbamazepine at a minimum of 400mg per day for at least 2 months and on a stable dose for at least 1 month. All study related clinic visits, testing and study medications are provided at no cost.
Compensation is provided.
If you would like to learn more about participating in this study, please send an e-mail message using the form below. Please be assured that your message has been received. This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.